Nobel Assembly announces Linda B. Buck as co-recipient of the 2004 Nobel Prize in Physiology or Medicine for work on olfactory receptors.
On 4 October 2004, the Nobel Assembly at the Karolinska Institute announced that Linda B. Buck, then at the Fred Hutchinson Cancer Research Center in Seattle, would receive the Nobel Prize in Physiology or Medicine together with Richard Axel. The prize recognized their landmark discoveries of odorant receptors and the organization of the olfactory system.
This announcement, made public in Stockholm and echoed by institutions such as Fred Hutch and the Howard Hughes Medical Institute, marked a pivotal moment in the history of neuroscience. Buck and Axel’s 1991 work had identified a large multigene family encoding olfactory receptors and mapped how sensory information from these receptors was organized and transmitted to the brain. By 2004, their findings had reshaped the scientific understanding of how organisms detect and discriminate an enormous variety of odors, providing a molecular and genetic framework for a sense that had long been considered elusive.
The significance of 4 October 2004 in women’s history is profound. Buck became one of the relatively few women to receive a Nobel Prize in the life sciences, joining a lineage that includes figures such as Gerty Cori and Rita Levi-Montalcini. Her recognition highlighted both the excellence of her research and the gradual, hard-won inclusion of women at the highest levels of scientific honor. The announcement also drew public attention to the contributions of women investigators at major research centers, encouraging young women to envision careers in experimental biology and neuroscience. In institutional and cultural terms, this date stands as a milestone in the visibility and validation of women’s leadership in fundamental biomedical discovery.